Germline genetic variability in pancreatic cancer risk and prognosis

M Gentiluomo, F Canzian, A Nicolini… - Seminars in cancer …, 2022 - Elsevier
Pancreatic cancer (PC), particularly its most common form, pancreatic ductal
adenocarcinoma (PDAC), is relatively rare but highly lethal. Knowledge about PC risk …

[HTML][HTML] Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms

B Smolkova, A Kataki, J Earl, I Ruz-Caracuel… - Critical Reviews in …, 2022 - Elsevier
Pancreatic neuroendocrine neoplasms (pNENs) are rare cancers with broad challenges for
their management. The main clinical obstacles are the high rate of patients diagnosed at …

Pancreatic neuroendocrine neoplasms: updates on genomic changes in inherited tumour syndromes and sporadic tumours based on WHO classification

H Ishida, AK Lam - Critical Reviews in Oncology/Hematology, 2022 - Elsevier
Pancreatic neuroendocrine neoplasms (PanNENs) are the neuroendocrine neoplasms with
greatest rate of increase in incidence. Approximately 10% of PanNENs arise as inherited …

[HTML][HTML] Epigenetic regulation in gastroenteropancreatic neuroendocrine tumors

JS Crabtree - Frontiers in Oncology, 2022 - frontiersin.org
Gastroenteropancreatic neuroendocrine neoplasms are a rare, diverse group of
neuroendocrine tumors that form in the pancreatic and gastrointestinal tract, and often …

[HTML][HTML] Current and new challenges in the management of pancreatic neuroendocrine tumors: the role of miRNA-based approaches as new reliable biomarkers

A Havasi, D Sur, SS Cainap, CV Lungulescu… - International Journal of …, 2022 - mdpi.com
Pancreatic neuroendocrine tumors (PanNETs) are rare tumors; however, their incidence
greatly increases with age, and they occur more frequently among the elderly. They …

Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers

M Andrea, T Weinschenk, O Schoor, J Fritsche… - US Patent …, 2022 - Google Patents
The present invention relates to peptides, proteins, nucleic acids and cells for use in
immunotherapeutic methods. In particular, the present invention relates to the …